GLP-1 drugs

The CBS News piece profiles patients and clinicians describing widespread use of GLP‑1 drugs in the U.S., now taken by over 30 million people. GLP‑1 therapies were a...

Starting July 1, 2026, CMS will operate a temporary pilot called the Medicare GLP-1 Bridge that allows some Medicare Part D beneficiaries enrolled in eligible plans ...

Insurers and employer plans have increasingly stopped covering GLP-1 medications when prescribed solely for weight loss; GoodRx research cited that plans covering Ze...

Recent retrospective analyses presented at an American Society of Clinical Oncology meeting report associations between GLP-1 medications and lower rates or slower p...

Neurologists are cautioning that GLP-1 receptor agonists (a class of diabetes and weight-loss drugs that includes semaglutide) can cause rapid weight loss that may b...

A CBS News report summarizes a new study that found an association between GLP-1 drug use and a 17% reduction in worker sick leave. The article suggests that weight-...

Teddi Mellencamp, a 44‑year‑old former Real Housewives of Beverly Hills cast member, said on her podcast that while undergoing treatment for stage 4 metastatic melan...

Insurance-claims research published as a JAMA research letter found that fewer than one in four patients remained on a GLP-1 medication after one year. Clinicians ci...

The U.S. Food and Drug Administration approved Foundayo (orforglipron), an oral once-daily GLP-1 medication developed by Eli Lilly for chronic weight management in a...

A large observational study of more than 600,000 U.S. veterans reported that people who began GLP-1 medications for diabetes were roughly 15–20% less likely to be di...

Bridal retailers report operational changes in response to widespread use of GLP-1 weight-loss drugs. Stores are carrying extra inventory, expediting more rush order...

CBS News 'Sunday Morning' (hosted by Jane Pauley) will air its June 7 broadcast with segments including: a cover story on the Broadway revival of Ragtime featuring i...